Accessibility: Skip TopNav
Figure 1
Waterfall plot showing percent change from baseline in total polyp burden at Week 13 for efficacy-evaluable patients receiving REC-4881 (4 mg QD)
Format
JPEG
Source
Recursion Pharmaceuticals, Inc.
Downloads
Original
Large
Medium
Small